Products

Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Goat Anti-Swine AIF1 Polyclonal Antibody

Product Overview

BioVenic goat anti-AIF1 antibody is designed to recognize porcine allograft inflammatory factor 1. The antibody can be used in the application of western blot, ELISA, immunohistochemistry.

Specifications

Application WB; ELISA; IHC

Clonality Polyclonal Antibody

Classification Primary Antibody

Clone A3Q1

Host Goat

Target Species Swine

Species Reactivity Swine; Canine; Feline

Specificity Swine AIF1

Purification Antigen Affinity Purified

Purity ≥ 90% (SDS-PAGE)

Concentration 0.5 mg/ml

Conjugation Unconjugated

Preservative and Stabilizer 0.02% Sodium azide (NaN₃), 0.5% BSA

Buffer 0.02% Tris Buffered Saline, pH 7.3

Physical State Liquid

Target Information

Swine AIF1, like AIF1 in other species, is an important protein in the field of immunology and inflammation research. It helps scientists investigate the complex interactions of the immune system and its role in various health and disease states in pigs.

Target Swine AIF1

Target Synonym AIF1;IBA1;Allograft inflammatory factor 1

UniProt ID P81076

Shipping and Storage

This product is shipped with gel ice packs. It is recommended to aliquot and store at -20°C on receipt. (up to 12 months). Avoid repeated freezing and thawing as this may denature the antibody. Storage in frost-free freezers is not recommended.

Documents

Datasheet

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

References

Piotrowska, Katarzyna, et al. "Over-expression of allograft inflammatory factor-1 (AIF-1) in patients with rheumatoid arthritis." Biomolecules 10.7 (2020): 1064.